Clinical outcomes of patients after propensity score matching with or without REBOA
| REBOA (n=22) | No-REBOA (n=22) | P value | |
| Gastrointestinal outcome | |||
| Feeding intolerance | 17 (77.3) | 6 (27.3) | 0.002 |
| Ileus | 6 (27.3) | 2 (9.1) | 0.118 |
| Diarrhea | 5 (22.7) | 2 (9.1) | 0.216 |
| Constipation | 17 (77.3) | 14 (63.6) | 0.510 |
| GRV (mL) | 100.0 (55.0–180.0) | 55.0 (0.0–135.0) | 0.073 |
| Time to feeding goal (days) | 7.5 (6.8–11.5) | 5.5 (3.0–8.5) | 0.022 |
| Parental nutrition | 4 (18.2) | 4 (18.2) | 1.000 |
| In-hospital mortality | 2 (9.1) | 2 (9.1) | 1.000 |
| Pneumonia | 7 (31.8) | 5 (22.7) | 0.736 |
| Acute kidney injury | 7 (31.8) | 5 (22.7) | 0.736 |
| KDIGO stage 1/2/3 | 0/4/3 | 0/2/3 | |
| Ventilator days | 8.0 (5.0–16.5) | 4.0 (0.0–8.8) | 0.023 |
| ICU length of stay (days) | 20.0 (13.0–41.0) | 11.0 (7.0–19.5) | 0.006 |
| Length of stay (days) | 49.0 (26.0–89.5) | 30.5 (13.8–58.0) | 0.106 |
Continuous variables are presented as median (IQR). Categorical variables are presented as number (%).
GRV, gastric residual volume; ICU, intensive care unit; KDIGO, the Kidney Disease Improving Global Outcomes; REBOA, resuscitative endovascular balloon occlusion of the aorta.